Opportunity ID: 326463

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-20-MRP-IA
Funding Opportunity Title: DoD Melanoma, Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 9
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 21, 2020
Last Updated Date: Apr 21, 2020
Original Closing Date for Applications: Sep 24, 2020
Current Closing Date for Applications: Sep 24, 2020
Archive Date: Oct 24, 2020
Estimated Total Program Funding: $20,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY20 MRP Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in melanoma research. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active duty Service members, Veterans, other military beneficiaries, and the American public.

The purpose of the Idea Award is to generate novel research avenues for investigation. The proposed research project should include a well-formulated, testable novel hypothesis based on strong scientific rationale and study design. The Idea Award is not intended to support a logical progression of an already established research project. A key characteristic of this funding opportunity is innovation. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Incremental advances, the next logical step, or switching a model system from one cancer to another cancer is not considered innovative.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 326463 Full Announcement-FY20 MRP IA -> MRP_FY20_IA_PA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00261170 Apr 21, 2020 Sep 24, 2020 View

Package 1

Mandatory forms

326463 RR_SF424_2_0-2.0.pdf

326463 AttachmentForm_1_2-1.2.pdf

326463 RR_PersonalData_1_2-1.2.pdf

326463 RR_KeyPersonExpanded_2_0-2.0.pdf

326463 RR_Budget_1_4-1.4.pdf

326463 PerformanceSite_2_0-2.0.pdf

Optional forms

326463 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-09T17:06:17-05:00

Share This Post, Choose Your Platform!

About the Author: